News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dr. Attila Endre Pavlath Joins The Board Of Directors Of ComInnex



8/8/2014 10:18:22 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BUDAPEST, HUNGARY--(Marketwired - August 07, 2014) - ComInnex, Inc., (www.cominnex.com) a privately held contract research and integrated discovery service organization announced today that Dr. Attila Endre Pavlath joined its Board of Directors.

Dr. Attila Endre Pavlath, a well known scientist and former ACS president will bring his strategic experience into the governing body of ComInnex. Dr. Pavlath's 6 decades of achievements are also recognized by the American Chemical Society at a dedicated session at the ACS 248th National Meeting & Exposition in San Francisco on August 12th, 2014 at 8:00 am (ww.acs.org).

ComInnex is a chemistry and medicinal chemistry service organization with strong interest and background in the development of chemical technologies that enables its partners to access novel chemical space and intellectual property. Its current technology innovation platform focuses on the development of synthetic tools towards novel non-flat fragment-like and lead-like molecules for lead identification and medicinal chemistry. To this end the company recently introduced its Smartdiversity™ platform that rapidly creates new IP space for medicinal chemistry. ComInnex technologies enable the company to penetrate chemical space not easily reachable by traditional laboratory techniques and develop unique and patentable molecular frameworks of high value for the pharmaceutical, agrochemical and chemical industries.

Dr. Ferenc Darvas, President and Chairman of ComInnex commented that "We are proud that Dr. Pavlath joins our Governing Board. We believe that his experience and significant achievements will be a great asset for the company and will help expand our value added innovative portfolio of offerings."

Dr. Pavlath added that "I am glad that I could join such a dynamic and innovative company like ComInnex at the governing level and join the experienced industry veterans in the management and Board level such as Dr. Ferenc Darvas, Dr. Gergely Makara and Dr. Laszlo Urge. I believe that together we will create and execute a strategy that will benefit customers significantly and keep ComInnex in the forefront of innovation."

About ComInnex:
ComInnex, Inc. is a custom chemistry, medicinal chemistry and chemical library provider in the EU. Its chemistry, medicinal chemistry and technology platform was formed via the fusion of powerful chemistry technology innovation at ComInnex with the outstanding chemistry and medicinal chemistry expertise of the former AMRI Hungary. Beyond offering excellence in traditional contract research, the company is also a breeding ground for innovative technologies in the service of chemistry and medicinal chemistry research: a partner where technology and medicinal chemistry meet to access novel and unique chemical space.

Board of Directors: Dr. Ferenc Darvas, Dr. Attila Endre Pavlath, Dr. Laszlo Urge, Dr. Ferenc Kalman, Dr. Gergely Makara, Alexander Drijver, Palne Tari


Contact:
Dr. Gergely Makara
CEO
ComInnex, Inc.
Zahony u. 7.
H-1031 Budapest, Hungary
Email: Email Contact
Phone: +36 1 880-8450
Fax: +36 1 880-8455
Web: http://www.cominnex.com



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
ComInnex
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES